{"schema_version":"secwatch.filing_event.v1","accession":"0000947871-26-000546","form_type":"8-K","ticker":"EMBC","cik":"0001872789","company_name":"Embecta Corp.","filed_at":"2026-05-15T13:15:29+00:00","discovered_at":"2026-05-15T13:16:00.297765+00:00","generated_at":"2026-05-15T13:16:09.935768+00:00","sec_items":["2.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Embecta completes acquisition of Owen Mumford for £100M upfront plus up to £50M earnout","bullets":["Acquisition completed May 15, 2026; Owen Mumford is a UK-based medical device and drug-delivery technology manufacturer.","Upfront cash payment of £100M at closing; up to £50M additional based on Aidaptus auto-injector sales through June 2029.","Strategic move to transform embecta into a broad-based medical supplies company serving obesity, diabetes, autoimmune, and anaphylaxis markets.","Adds differentiated drug-delivery platform with Aidaptus next-generation auto-injector and strong IP portfolio.","Combines Owen Mumford's device design, molding, and assembly with embecta's global commercial infrastructure and manufacturing scale."],"urls":{"canonical":"https://secwatch.observer/filing/0000947871-26-000546","json":"https://secwatch.observer/filing/0000947871-26-000546.json","markdown":"https://secwatch.observer/filing/0000947871-26-000546.md","text":"https://secwatch.observer/filing/0000947871-26-000546.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1872789/000094787126000546/0000947871-26-000546-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1872789/000094787126000546/ss6329586_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T13:16:09.935768+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"612c0562469babd3de762ad114000cd4d633995d","claim":"Embecta Corp. completed an acquisition involving Owen Mumford Holdings Limited for £100 million upfront cash plus up to £50 million milestone payments (closed 2026-05-15).","evidence_excerpt":"Ellen Owen, Kim Priddis and Nancy Millington. Pursuant to the terms and conditions of the Purchase Agreement, embecta acquired Owen Mumford for an upfront cash payment of £100 million at closing (subject to customary adjustments, including for closing net cash) and will pay up to an additional £50 million upon the achievement of certain commercial milestones","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1872789/000094787126000546/0000947871-26-000546-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Owen Mumford Holdings Limited"},{"label":"Consideration","value":"£100 million upfront cash plus up to £50 million milestone payments"},{"label":"Closing","value":"2026-05-15"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}